|---|---|
|Conditional recommendation based on low-quality evidence; may consider tofacitinib if the patient prefers an oral therapy.|Conditional recommendation based on low-quality evidence; may consider tofacitinib if the patient prefers an oral therapy.|
|13. Add apremilast to current OSM therapy over switching to apremilast (PICO 22b)|Low (83, 84, 108)|